AbLWR:A Context-Aware Listwise Ranking Framework for Antibody-Antigen Binding Affinity Prediction via Positive-Unlabeled Learning
- URL: http://arxiv.org/abs/2604.11272v1
- Date: Mon, 13 Apr 2026 10:28:36 GMT
- Title: AbLWR:A Context-Aware Listwise Ranking Framework for Antibody-Antigen Binding Affinity Prediction via Positive-Unlabeled Learning
- Abstract summary: AbLWR (Antibody-antigen binding affinity List-Wise Ranking) is a novel framework that reformulates the conventional affinity regression task as a listwise ranking problem.<n>To mitigate label sparsity, AbLWR incorporates a PU (Positive-Unlabeled) learning mechanism leveraging a dual-level contrastive objective and meta-optimized refinement to learn robust representations.
- Score: 31.99809102852669
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: Accurate prediction of antibody-antigen binding affinity is fundamental to therapeutic design, yet remains constrained by severe label sparsity and the complexity of antigenic variations. In this paper, we propose AbLWR (Antibody-antigen binding affinity List-Wise Ranking), a novel framework that reformulates the conventional affinity regression task as a listwise ranking problem. To mitigate label sparsity, AbLWR incorporates a PU (Positive-Unlabeled) learning mechanism leveraging a dual-level contrastive objective and meta-optimized label refinement to learn robust representations. Furthermore, we address antigenic variation by employing a homologous antigen sampling strategy where Multi-Head Self-Attention (MHSA) explicitly models inter-sample relationships within training lists to capture subtle affinity nuances. Extensive experiments demonstrate that AbLWR significantly outperforms state-of-the-art baselines, improving the Precision@1 (P@1) by over 10$\%$ in randomized cross-validation experiments. Notably, case studies on Influenza and IL-33 validate its practical utility, demonstrating robust ranking consistency in distinguishing subtle viral mutations and efficiently prioritizing top-tier candidates for wet-lab screening.
Related papers
- AbICL: In-Context Learning for Antigen-Specific Antibody Affinity Ranking [14.780636181646818]
We propose AbICL, an ICL framework for antigen-specific antibody affinity ranking.<n> experiments on the AbRank benchmark demonstrate that AbICL consistently outperforms existing ranking baselines.<n>These findings highlight the potential of ICL as an effective paradigm for antigen-specific antibody affinity ranking.
arXiv Detail & Related papers (2026-07-07T05:06:53Z) - Preference-based Antibody Expression Ranking: Scaling with Large-scale Weak Supervision [1.5623752145311105]
We propose a unified preference-based learning framework that integrates scarce quantitative expression data with large-scale weak positive supervision from immunization data.<n>We adapt Direct Preference Optimization to protein language models by introducing a union-masked log-likelihood approximation and IMGT-based alignment.<n>Our results demonstrate that preference learning can effectively learn from weak supervision, providing a scalable solution for antibody expressibility optimization in data-constrained settings.
arXiv Detail & Related papers (2026-06-29T03:34:12Z) - ABConformer: Physics-inspired Sliding Attention for Antibody-Antigen Interface Prediction [3.947298454012977]
We present ABCONFORMER, a model based on the Conformer backbone that captures both local and global features of a biosequence.<n>ABCONFORMER can accurately predict paratopes and antigens given the antibody and sequence, and predict pan-epitopes on the antigen without antibody information.
arXiv Detail & Related papers (2025-09-27T11:12:04Z) - BURN: Backdoor Unlearning via Adversarial Boundary Analysis [73.14147934175604]
Backdoor unlearning aims to remove backdoor-related information while preserving the model's original functionality.<n>We propose Backdoor Unlearning via adversaRial bouNdary analysis (BURN), a novel defense framework that integrates false correlation decoupling, progressive data refinement, and model purification.
arXiv Detail & Related papers (2025-07-14T17:13:06Z) - AbRank: A Benchmark Dataset and Metric-Learning Framework for Antibody-Antigen Affinity Ranking [3.6572710422983445]
AbRank is a large-scale benchmark and evaluation framework that reframes affinity prediction as a pairwise ranking problem.<n>We introduce WALLE-Affinity, a graph-based approach that integrates protein language model embeddings with structural information to predict pairwise binding preferences.
arXiv Detail & Related papers (2025-06-21T23:34:46Z) - Sequence-Only Prediction of Binding Affinity Changes: A Robust and Interpretable Model for Antibody Engineering [9.789817970737666]
A pivotal area of research in antibody engineering is to find effective modifications that enhance antibody-antigen binding affinity.<n>Deep learning solutions offer an alternative by modeling antibody structures to predict binding affinity changes.<n>We propose ProtAttBA, a deep learning model that predicts binding affinity changes based solely on the sequence information of antibody-antigen complexes.
arXiv Detail & Related papers (2025-05-14T15:00:46Z) - Noisy Correspondence Learning with Self-Reinforcing Errors Mitigation [63.180725016463974]
Cross-modal retrieval relies on well-matched large-scale datasets that are laborious in practice.
We introduce a novel noisy correspondence learning framework, namely textbfSelf-textbfReinforcing textbfErrors textbfMitigation (SREM)
arXiv Detail & Related papers (2023-12-27T09:03:43Z) - Evaluating Zero-Shot Scoring for In Vitro Antibody Binding Prediction
with Experimental Validation [0.08968838300743379]
We compare 8 common scoring paradigms based on open-source models to classify antibody designs as binders or non-binders.
Results show that existing methods struggle to detect binders, and performance is highly variable across antigens.
arXiv Detail & Related papers (2023-12-07T23:34:03Z) - xTrimoABFold: De novo Antibody Structure Prediction without MSA [77.47606749555686]
We develop a novel model named xTrimoABFold to predict antibody structure from antibody sequence.
The model was trained end-to-end on the antibody structures in PDB by minimizing the ensemble loss of domain-specific focal loss on CDR and the frame-aligned point loss.
arXiv Detail & Related papers (2022-11-30T09:26:08Z) - Reprogramming Pretrained Language Models for Antibody Sequence Infilling [72.13295049594585]
Computational design of antibodies involves generating novel and diverse sequences, while maintaining structural consistency.
Recent deep learning models have shown impressive results, however the limited number of known antibody sequence/structure pairs frequently leads to degraded performance.
In our work we address this challenge by leveraging Model Reprogramming (MR), which repurposes pretrained models on a source language to adapt to the tasks that are in a different language and have scarce data.
arXiv Detail & Related papers (2022-10-05T20:44:55Z) - Improved Certified Defenses against Data Poisoning with (Deterministic)
Finite Aggregation [122.83280749890078]
We propose an improved certified defense against general poisoning attacks, namely Finite Aggregation.
In contrast to DPA, which directly splits the training set into disjoint subsets, our method first splits the training set into smaller disjoint subsets.
We offer an alternative view of our method, bridging the designs of deterministic and aggregation-based certified defenses.
arXiv Detail & Related papers (2022-02-05T20:08:58Z) - Exploiting Sample Uncertainty for Domain Adaptive Person
Re-Identification [137.9939571408506]
We estimate and exploit the credibility of the assigned pseudo-label of each sample to alleviate the influence of noisy labels.
Our uncertainty-guided optimization brings significant improvement and achieves the state-of-the-art performance on benchmark datasets.
arXiv Detail & Related papers (2020-12-16T04:09:04Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.